Literature DB >> 28982315

Bacterial Protein Mimetic of Peptide Hormone as a New Class of Protein- based Drugs.

Sergueï O Fetissov1,2, Romain Legrand3, Nicolas Lucas3.   

Abstract

Specific peptide molecules classified as hormones, neuropeptides and cytokines are involved in intercellular signaling regulating various physiological processes in all organs and tissues. This justifies the peptidergic signaling as an attractive pharmacological target. Recently, a protein mimetic of a peptide hormone has been identified in Escherichia coli suggesting the potential use of specific bacterial proteins as a new type of peptide-like drugs. We review the scientific rational and technological approaches leading to the identification of the E. coli caseinolytic protease B (ClpB) homologue protein as a conformational mimetic of α-melanocyte-stimulating hormone (α-MSH), a melanocortin peptide critically involved in the regulation of energy homeostasis in humans and animals. Theoretical and experimental backgrounds for the validation of bacterial ClpB as a potential drug are discussed based on the known E. coli ClpB amino acid sequence homology with α-MSH. Using in silico analysis, we show that other protein sources containing similar to E. coli ClpB α-MSH-like epitopes with potential biological activity may exist in Enterobacteriaceae and in some Brassicaceae. Thus, the original approach leading to the identification of E. coli ClpB as an α-MSH mimetic protein can be applied for the identification of mimetic proteins of other peptide hormones and development of a new type of peptide-like protein-based drugs. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Peptide hormone; energy metabolism; gut microbiota; melanocortin; molecularzzm321990mimicry; neuropeptide; proteomics.

Mesh:

Substances:

Year:  2019        PMID: 28982315     DOI: 10.2174/0929867324666171005110620

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  5 in total

1.  Hafnia alvei HA4597 Strain Reduces Food Intake and Body Weight Gain and Improves Body Composition, Glucose, and Lipid Metabolism in a Mouse Model of Hyperphagic Obesity.

Authors:  Nicolas Lucas; Romain Legrand; Camille Deroissart; Manon Dominique; Saïda Azhar; Marie-Anne Le Solliec; Fatima Léon; Jean-Claude do Rego; Pierre Déchelotte; Sergueï O Fetissov; Grégory Lambert
Journal:  Microorganisms       Date:  2019-12-23

2.  Gut bacterial ClpB-like gene function is associated with decreased body weight and a characteristic microbiota profile.

Authors:  María Arnoriaga-Rodríguez; Jordi Mayneris-Perxachs; Aurelijus Burokas; Vicente Pérez-Brocal; Andrés Moya; Manuel Portero-Otin; Wifredo Ricart; Rafael Maldonado; José-Manuel Fernández-Real
Journal:  Microbiome       Date:  2020-04-30       Impact factor: 14.650

Review 3.  The Microbiota and the Gut-Brain Axis in Controlling Food Intake and Energy Homeostasis.

Authors:  Marina Romaní-Pérez; Clara Bullich-Vilarrubias; Inmaculada López-Almela; Rebeca Liébana-García; Marta Olivares; Yolanda Sanz
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

4.  Phylogenetic and expression dynamics of tomato ClpB/Hsp100 gene under heat stress.

Authors:  Sanober Gul; Kausar Nawaz Shah; Rashid Mehmood Rana; Muhammad Azam Khan; Ahmed M El-Shehawi; Mona M Elseehy
Journal:  PLoS One       Date:  2021-08-13       Impact factor: 3.240

Review 5.  Shedding light on biological sex differences and microbiota-gut-brain axis: a comprehensive review of its roles in neuropsychiatric disorders.

Authors:  Parnian Shobeiri; Amirali Kalantari; Antônio L Teixeira; Nima Rezaei
Journal:  Biol Sex Differ       Date:  2022-03-25       Impact factor: 5.027

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.